South San Francisco, Calif., January Thirty, 2009 - (HSMN NewsFeed) - The special committee of the Board of Directors of Genentech, Inc. (NYSE: DNA) today urged shareholders to take no action at this time with respect to the announcement by Roche that it int…
Biopharmaceuticals, Mergers & Acquisitions
Genentech, Roche Group

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Special Committee of Genentech Board of Directors Responds to Roche’s Announced Intention to Commence a Tender Offer”
Leave a Comment